Anti-PD-L1 antibodies and methods of making and using thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11560431
SERIAL NO

16615112

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The application provides the anti-PD-L1 monoclonal antibodies, antigen binding portions thereof, therapeutic compositions thereof and/or nucleic acid encoding the same, and their use to upregulate the function of T-cells to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adamo, Jeffrey B Seattle, US 4 3
Fallen, Jonathan K Quincy, US 2 0
Gao, Zeren Redmond, US 127 1388
Jensen, Anne E Mill Creek, US 8 4
Kovacevich, Brian Snohomish, US 37 1651
Renshaw, Blair Renton, US 17 8
Tan, Phil Edmonds, US 10 5
Xia, Dong Redmond, US 21 50
Zhu, Yi Chengdu, CN 152 441

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 24, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 24, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 24, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00